LONDON--GlaxoSmithKline PLC (GSK.LN) Thursday said it submitted a regulatory application to the European Medicines Agency for its experimental malaria vaccine.

A "positive opinion" from the EMA would move GSK a step closer to marketing the RTS,S vaccine to individual countries in sub-Saharan Africa.

Shares at 1012 GMT down 9 pence or 0.6% at 1,472 pence.

Write to Ed Ballard at ed.ballard@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

GSK (NYSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more GSK Charts.
GSK (NYSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more GSK Charts.